Ovid Therapeutics Expected Short fall
| OVID Stock | | | USD 2.14 0.23 12.04% |
The Expected Short fall technical lookup provides context for Ovid Therapeutics and related instruments. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context.
Your Equity Center provides context for diversified portfolio construction. Such insight adds context to allocation decisions within a diversified portfolio. This reflects a position in Ovid Therapeutics within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
New to investing in Ovid Stock? Start with our
How to Invest in Ovid Stock guide for a step-by-step overview.
Ovid Therapeutics has current Expected Short fall of
-4.63. Expected shortfall (or ES) is a risk measure that evaluates the market risk of an equity instrument. It is an alternative to value at risk that is more sensitive to the shape of the loss distribution in the tail of the distribution. The expected shortfall at a particular level is the expected return on the portfolio in the worst percent of the cases. Expected shortfall is also called conditional value at risk (CVaR), average value at risk (AVaR), and expected tail loss (ETL).
Expected Shortfall | = | Conditional VAR |
| = | -4.63 | |
Ovid Therapeutics Expected Short fall Peers Comparison
Ovid Expected Short fall Relative To Other Indicators
Ovid Therapeutics is rated
below average. in expected short fall category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors .
ES evaluates the value (or risk) of an investment in a conservative way, focusing on the less profitable outcomes. For high values of it ignores the most profitable but unlikely possibilities, for small values of it focuses on the worst losses. On the other hand, unlike the discounted maximum loss even for lower values of expected shortfall does not consider only the single most catastrophic outcome. Expected shortfall is a coherent, and moreover a spectral, measure of financial portfolio risk.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.